I know that last week’s announcement of our plans to combine our global generics business with Teva is still fresh on many of your minds. We are confident that this decision is the right one for our global generics business and for the branded business, but we know that there are many unanswered questions. The leadership team and I are committed to communicating with you and being available to answer your questions. We will answer questions at today’s global town hall meeting and expect to post more answers within the next week or so.